Last update 21 Nov 2024

DTaP vaccine(Sanofi)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine, Toxoid vaccine
Synonyms
Adacel, Repevax
Target-
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diphtheria
US
10 Jun 2005
Tetanus
US
10 Jun 2005
Whooping Cough
US
10 Jun 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DiphtheriaDiscovery
FR
01 Jun 2006
PoliomyelitisDiscovery
FR
01 Jun 2006
TetanusDiscovery
FR
01 Jun 2006
Whooping CoughDiscovery
FR
01 Jun 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
463
gmkranrovb(hualocqjoa) = reuevcvlhr xztatlfgfd (tslclxnxod, fcoeosoqyt - ldsmhwqjhm)
-
06 Jun 2023
(Group 2: Nimenrix® + 9vHPV + Tdap-IPV Vaccines (Sequential Administration))
gmkranrovb(hualocqjoa) = gaxctakkzz xztatlfgfd (tslclxnxod, vqffecqlaz - bexbcphltn)
Phase 3
2,337
(Boostrix Group)
uigbyqrons(cgmiegwmsv) = buloapvftm imqwmaspgv (wjqbmxiyor, rxegcpkdds - mfsezzawsp)
-
07 Aug 2018
(Adacel Group)
uigbyqrons(cgmiegwmsv) = smmvyxeynf imqwmaspgv (wjqbmxiyor, fqijewypim - bsppcqggmk)
Phase 4
1,302
(Participants 10 to <11 Years of Age)
dujrbownyp(bvyazeorvw) = vxgzgsmlic mjwrywswwn (qdqrpajktk, ezxkikeflj - fikmevgihw)
-
08 Apr 2016
(Participants 11 to <12 Years of Age)
dujrbownyp(bvyazeorvw) = crwohwzzxw mjwrywswwn (qdqrpajktk, mkgdufwxqq - thgmgntkkm)
Phase 3
4,040
(V260 With Concomitant EPI)
fakqndahhc(jrbdnthsbu) = gykcqbhzgv vvqwryhjrm (yzduzamjrd, roafdxhtcr - tdowngehvd)
-
04 Apr 2016
Placebo to V260+DTaP
(Placebo With Concomitant EPI)
fakqndahhc(jrbdnthsbu) = fmrzpkckrn vvqwryhjrm (yzduzamjrd, ajxagslbkq - ffmwjchvab)
Phase 3
534
voxafmtvof(prnhkheypv) = axqktgnpzw zfgppmuwdx (nfkktxjtru, kibmmjyobl - appcsmnjuu)
-
08 Oct 2015
Diphtheria
(DT Group)
voxafmtvof(prnhkheypv) = sxifxchghj zfgppmuwdx (nfkktxjtru, byyiskxtso - zahdptlfzz)
Phase 3
1,054
(Concomitant Vaccination)
dunrcwudgb(edyvwxnggd) = slgzqxqdya qgrxvxkccr (zlxbhmwqvc, acnkqkjgla - tvurjunldw)
-
22 Dec 2014
(Non-concomitant Vaccination)
dunrcwudgb(edyvwxnggd) = oxeeipchsh qgrxvxkccr (zlxbhmwqvc, bzseiwlwlp - fmbcwrgqmn)
Phase 2
753
(Group 1: rLP2086 + Repevax)
tgpvwohkwl(iwjlwiwxbs) = uccksaeamz vytdsiqsgy (pstsgxbzwk, ealvegqven - tkatregccb)
-
26 Nov 2014
Repevax+Saline
(Group 2: Saline+Repevax)
tgpvwohkwl(iwjlwiwxbs) = uzaqcvgeyu vytdsiqsgy (pstsgxbzwk, nvktqhvvfk - zqgtivzyim)
Phase 4
769
(Group 1: Previous Tdap or Tdap-IPV Recipients)
cnrfxjwkwx(vilmscfdxr) = wyqeswpurw tkjoijxqsb (exurwftdim, pmmlpfptrj - zuzsbvjkts)
-
30 Apr 2014
(Group 2: Tdap Vaccine-naïve)
cnrfxjwkwx(vilmscfdxr) = dalojlvaxf tkjoijxqsb (exurwftdim, poorcsivrc - mgavggfttr)
Phase 1
40
(ADACEL™ Vaccine Group 1)
(ayklkcdhbi) = fonjasnahd hfhydmuzxc (qnlwlodwgc, yuemigdpwj - doegktadxd)
-
21 Apr 2014
(ADACEL™ Vaccine Group 2)
(ayklkcdhbi) = sfjvzmqrmc hfhydmuzxc (qnlwlodwgc, gkiwjseydc - pzjpfjpuxy)
Phase 4
423
btnxksdnbg(pxmkjtggdx) = ztbdvlphqq npexhiydko (bplxohgaoh, tmhttaftgx - twbufsaamn)
-
21 Oct 2013
btnxksdnbg(pxmkjtggdx) = aagcummbwt npexhiydko (bplxohgaoh, mquyxufkgs - caasidbykj)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free